Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.

Abstract

Systematic data from three studies suggest that anticholinergic antiparkinsonism agents, when added to ongoing neuroleptic treatment in schizophrenics, have the effect of arresting or reversing therapeutic changes, and when given alone to untreated patients, tend to further worsen their psychosis. The countertherapeutic effects of anticholinergic drugs are reflected particularly in parameters which represent features of schizophrenic psychosis most consistently responsive to neuroleptics. It is proposed that these anticholinergic effects are central in origin and point to the involvement of cholinergic mechanisms in the expression of schizophrenic psychosis and its improvement with neuroleptic medication.

Statistics

0200400'80'83'87'91'95'99'03'07'11'15
Citations per Year

1,095 Citations

Semantic Scholar estimates that this publication has 1,095 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Singh1979TherapeuticAB, title={Therapeutic antagonism between anticholinergic antiparkinsonism agents and neuroleptics in schizophrenia. Implications for a neuropharmacological model.}, author={Madhusudan Man Singh and Stanley R. Kay}, journal={Neuropsychobiology}, year={1979}, volume={5 2}, pages={74-86} }